A surgical procedure in which part or all of a damaged or diseased cornea is replaced by healthy corneal tissue from a donor.
1
Recurrent granular deposits developed in the corneal graft 14 months after surgery.
2
The FK506 nanospheres may be valuable in suppressing corneal graft rejection.
3
After completion of the vitrectomy, the Aachen-KPro was replaced by a 7 mm corneal graft.
4
The most common approach is a corneal graft followed by cataract surgery at a later date.
5
The corneal graft was clear after surgery in four eyes, and edema was found in three cases.
6
Background: Gene transfer to a donor cornea ex vivo can modulate corneal graft failure in experimental animal models.
7
In all eyes, no disease recurrence or corneal graft rejection was observed during the follow-up period, and graft transparency was maintained.
8
We describe a variant of the triple procedure in which phacoemulsification is followed by a corneal graft using the big-bubble DALK technique.
9
The outgrowth of corneal epithelial cells onto a polymeric substrate is expected to be the primary event in the epithelialization of a synthetic corneal graft.
10
Intraocular inflammation (uveitis and uveoretinitis) and corneal graft rejection constitute two of the more common inflammatory conditions affecting the eye leading to considerable morbidity (blindness).
11
A second option is simultaneous corneal grafts with cataract extraction and intraocular lens implantation.
12
Corneal grafts remained clear for 1 year in 65% of eyes.
13
Results: The number of corneal grafts increased by 30.7% from 2002-2006 to 2007-2011 (from 1567 to 2048).
14
Conclusions: Our findings show that the corneal grafts in the reported SCD pedigree remained clear with no rejection or disease recurrence over the long term.
15
Methods: The surgical reports of corneal grafts performed during 2002-2011, using tissues supplied by the Eye Bank of Piedmont (Italy), were reviewed retrospectively.